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Background: Hydrogen sulfide (H2S), an endogenous gaseotransmitter/modulator, is becoming appreciated that it
may be involved in a wide variety of processes including inflammation and nociception. However, the role for H2S
in nociceptive processing in trigeminal ganglion (TG) neuron remains unknown. The aim of this study was designed
to investigate whether endogenous H2S synthesizing enzyme cystathionine-β-synthetase (CBS) plays a role in
inflammatory pain in temporomandibular joint (TMJ).
Methods: TMJ inflammatory pain was induced by injection of complete Freund’s adjuvant (CFA) into TMJ of adult
male rats. Von Frey filaments were used to examine pain behavioral responses in rats following injection of CFA or
normal saline (NS). Whole cell patch clamp recordings were employed on acutely isolated TG neurons from rats
2 days after CFA injection. Western blot analysis was carried out to measure protein expression in TGs.
Results: Injection of CFA into TMJ produced a time dependent hyperalgesia as evidenced by reduced escape
threshold in rats responding to VFF stimulation. The reduced escape threshold was partially reversed by injection of
O-(Carboxymethyl) hydroxylamine hemihydrochloride (AOAA), an inhibitor for CBS, in a dose-dependent manner.
CFA injection led to a marked upregulation of CBS expression when compared with age-matched controls. CFA
injection enhanced neuronal excitability as evidenced by depolarization of resting membrane potentials, reduction
in rheobase, and an increase in number of action potentials evoked by 2 and 3 times rheobase current stimulation
and by a ramp current stimulation of TG neurons innervating the TMJ area. CFA injection also led to a reduction of
IK but not IA current density of TG neurons. Application of AOAA in TMJ area reduced the production of H2S in TGs
and reversed the enhanced neural hyperexcitability and increased the IK currents of TG neurons.
Conclusion: These data together with our previous report indicate that endogenous H2S generating enzyme CBS
plays an important role in TMJ inflammation, which is likely mediated by inhibition of IK currents, thus identifying a
specific molecular mechanism underlying pain and sensitization in TMJ inflammation.
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Hydrogen sulfide (H2S), a gas synthesized by the en-
dogenous enzymes cystathionine-β-synthetase (CBS)
and cystathionine-γ-lyase (CSE), is increasingly recognized
as a biologically important signaling molecule in various
tissues and pathophysiological processes including pain
and inflammation [1-7]. Its putative role as a neurotrans-
mitter is supported by recent reports on its effects on hip-
pocampal neurons as well as peripheral sensory neurons
[7-9]. With respect to the latter, intraplantar injection of
NaHS (a commonly used H2S donor) in rat hindpaws pro-
duces mechanical hyperalgesia [8]. H2S generation is en-
hanced in formalin [9] and carrageenan [10] model of
persistent inflammatory pain. Colonic administration of
H2S enhances pain behaviors in response to CRD in mice
[3] and rats [11]. Although there is a discrepancy in the
processing of nociceptive signaling [12], a growing body of
evidence suggests that H2S plays an important effect on
primary sensory neurons innervating somatic and visceral
organs [8,13,14]. However, the role of H2S on trigeminal
ganglion (TG) neurons under pathophysiological condi-
tions remains unknown.
We have previously demonstrated that the endogenous
H2S producing enzyme cystathionine-β-synthetase (CBS)
was abundantly expressed in rat TG neurons [15]. Appli-
cation of H2S donor NaHS enhanced excitability and
suppressed the voltage-gated IK of TG neurons in vitro
and reduced escape threshold of in healthy rats [15].
These findings suggest that CBS-H2S signaling pathway
plays an important role in nociceptive pathway in TG
under physiological conditions. However, whether CBS-
H2S signaling pathway plays a role in TG neurons under
pathophysiological conditions is unclear. The aims of
the present study were therefore to determine roles of
the endogenous H2S synthyzing enzyme CBS in TGs in
rats with TMJ inflammation. We hypothesized that TMJ
inflammation-induced hyperalgesia is mediated by up-
regulation of cbs gene expression and that activation of
CBS-H2S signaling enhances neuronal excitability via sup-
pression of potassium currents of TMJ-projecting TG
neurons, thus contributing to hyperalgesia in TMJ after
inflammation. Since we have showed that NaHS suppress
the IK current density in our previous study, therefore,
in the present study, we further investigated the role of
voltage-gated K channels in TMJ inflammation. To test
this hypothesis, we examined cbs gene expression and
determined neuronal excitability and potassium current
densities of TMJ-projecting TG neurons in an experi-
mental rat model of TMJ inflammation induced by CFA
injection. We demonstrated an upregulation of CBS ex-
pression, enhanced neuronal excitability, and an inhib-
ition of sustained potassium current (IK) density of TG
neurons after CFA injection. Administration of a CBS
inhibitor reversed hyperexcitability, increased IK currentdensity of TG neurons, and attenuated pain responses.
These observations support a pro-nociceptive role for
H2S in TMJ inflammatory pain.
Methods and materials
Animals
Experiments were performed on adult male Sprague-
Dawley rats (220 ± 20 g). Animals were housed under
controlled conditions (07:00 ~ 19:00, lighting, 24 ± 2°C)
with free access to a standard laboratory diet and fresh
water. Care and handling of these animals were ap-
proved by the Institutional Animal Care and Use Com-
mittee of Soochow University and were in accordance
with the guidelines of the International Association for
the Study of Pain.
DiI labeling
Temporomandibular joint receptive field specific TG
neurons were labeled by injection of 1, 19-dioleyl-3, 3,
39, 3-tetramethy-lindocarbocyanine methanesulfonate
(DiI; Invitrogen, Carlsbad, California) as described previ-
ous [16]. The skin overlying the TMJ was shaved. The
injection site was identified by palpating the zygomatic
arch and mandible. DiI (25 mg in 0.5 ml methanol) was
slowly injected into TMJ (1 μl/site, 3 sites in each side).
Multiple small injections of the tracers were made to limit
the spread of the tracer into untargeted tissues [17]. To
prevent leakage, needle was left in place for ~2 min for
each injection. Ten days later, the TGs were dissected out
for patch clamp recordings. The appearance of the in-
jected tracer in neurons indicates their innervation zone
in the overlying skin.
Induction of TMJ inflammation
To induce TMJ inflammation, Complete Freund’s Adju-
vant (CFA) (50 μl, 1:1 oil/saline suspension, Sigma, St.
Louis, MO) was injected into the right side of the TMJ
capsule, as described in previous studies [16,18,19]. For
control rats, 50 μl of normal saline (NS) was injected
into the TMJ capsule. To prevent leakage, CFA or NS
was injected slowly over a time span of 2 min and the
needle was left in place for ~2 min.
Mechanical threshold for escape behavior
On the day of testing, rats were weighed and virissas
were carefully shaved. The mechanical threshold for es-
cape behavior of ipsilateral and contralateral facial skin re-
gions were tested as described previously [15]. The
mechanical stimulation was applied to the skin above the
inflamed TMJ. In brief, rats were first placed individually
in small plastic cages and were allowed to adapt to the ob-
servation cage and testing environment for ~1 hr. During
this period, the experimenter slowly reached into the cage
to touch the walls of the cage with a plastic rod. After the
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series of mechanical stimulations were started. The mech-
anical response threshold of escape behavior was mea-
sured in control and inflamed rats. A graded series of von
Frey filaments were used. The filaments produced a bend-
ing force of 0.55, 0.93, 1.61, 1.98, 2.74, 4.87, 7.37, 11.42,
15.76, 20.30, and 38.69 g. A descending series of the fila-
ments were used when the rat responded to the starting
filament. Each filament was tested five times at an interval
of a few seconds. If head withdrawal was observed at least
three times after probing with a filament, the rat was con-
sidered responsive to that filament. The response thresh-
old was defined as the lowest force of the filaments that
produced at least three withdrawal responses in five tests.
The response was observed to belong to one or more of
the following responses: 1) The rat slowly turns the head
away or briskly moves it backward when the stimulation is
applied, and sometimes a single face wipe ipsilateral to the
stimulated area occurs; 2) The rat avoids further contact
with the stimulus object, either passively by moving its
body away from the stimulating object to assume a
crouching position against the cage wall, or actively by
attacking the stimulus object, making biting and grabbing
movements; 3) The rat displays an uninterrupted series of
at least three face-wash strokes directed toward the stimu-
lated facial area [15,20].
Dissociation of TG neurons
Isolation of TG neurons from adult male rats has been
described previously [21,22]. Briefly, animals 10 days
after injection of DiI were killed by cervical dislocation,
followed by decapitation. The TGs were then bilaterally
dissected out and transferred to an ice-cold, oxygenated
fresh dissecting solution, which contained (in mM): 130
NaCl, 5 KCl, 2 KH2PO4, 1.5 CaCl2, 6 MgSO4, 10 glucose,
and 10 HEPES, pH 7.2 (osmolarity: 305 mOsm). After
removal of connective tissue, ganglia were transferred to
5 ml of dissecting solution containing collagenase D
(1.8–2.0 mg/ml, Roche; Indianapolis, IN) and trypsin
(1.2 mg/ml, Sigma; St. Louis, MO) and incubated for
1.5 hrs at 34.5°C. TGs were then taken from the enzyme
solution, washed, and transferred to 2 ml of the dissect-
ing solution containing DNase (0.5 mg/ml, Sigma, St.
Louis, MO). A single-cell suspension was subsequently
obtained by repeated trituration through flame-polished
glass pipettes. Cells were plated onto acid-cleaned glass
coverslips.
Patch-clamp recordings
As described previously [15], coverslips containing ad-
herent TG cells were put in a small recording chamber
(0.5 ml volume) and attached to the stage of an inverting
microscope (Olympus, Japan). For patch-clamp record-
ing experiments, cells were continuously superfused(1.5 ml/min) at room temperature with normal external
solution containing (in mM) 130 NaCl, 5 KCl, 2 KH2PO4,
2.5 CaCl2, 1 MgCl2, 10 HEPES, and 10 glucose, with pH
adjusted to 7.4 with NaOH (osmolarity: 295-300 mOsm).
DiI-labeled neurons were identified by the bright red
fluorescence in the cytoplasm. Recording pipettes were
pulled from borosilicate glass tubing using a horizontal
puller (P-97, Sutter Instruments) and typically had a resist-
ance of 3.5-4.5MΩ when filled with normal external solu-
tion before being used immediately to obtain a gigaohm
seal. Tip potential was zeroed before membrane-pipette
seals were formed. The voltage was clamped at -60 mV
by an EPC10 amplifier (HEKA, Germany). Capacitive
transients were corrected using capacitive cancellation
circuitry on the amplifier that yielded the whole cell
capacitance and access resistance. Up to 80% of the
series resistance was compensated electronically. Con-
sidering the peak outward current amplitudes of 10 nA,
the estimated voltage errors from the uncompensated
series resistance would be 10 mV. The leak currents
at -60 mV were always below 20 pA and were not cor-
rected. The action potentials (APs) were filtered at 2–
5 kHz and sampled at 50 or 100 μs/point. Data were
acquired and stored on a computer for later analysis
using Patch Master (HEKA, Germany). All experiments
were performed at room temperature (~22°C). Only
neurons with a stable initial resting potential, which
drifted by less than 2–3 mV during the 10 min of base-
line recording, were used in these experiments. Cells
were characterized by their resting membrane poten-
tials, input resistances (Rm) and cell capacitances.
Stimulating ramps of linearly increasing current (range
0.1, 0.3 and 0.5 nA/s) were chosen to produce more
APs over a 1-second depolarization for each tested
neuron. In addition to the number of APs during the
ramp, the AP threshold, AP amplitude and duration
elicited by current stimulation were analyzed in this
study as described previously [15].
Isolation of voltage-gated potassium (KV) currents
To record KV currents, Na
+ in control external solution
was replaced with equimolar choline and Ca2+ concentra-
tion was reduced to 0.03 mM to suppress Ca2+ currents
and to prevent Ca2+ channels becoming Na+ conducting.
The reduced external Ca2+ would also be expected to
suppress Ca2+-activated K+ current [23]. The following
two kinetically distinct Kv currents were isolated by the
biophysical analysis and pharmacological approaches
described in previous studies: IA and IK [15,24,25]. IA
and IK were separated biophysically by manipulating the
holding potentials. For total voltage-gated potassium
current (ITotal), the membrane potential was held at -100 mV
and voltage steps were from -50 to +90 mV with10-mV
increments and 400 ms duration. For sustained voltage-
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held at -50 mV and the voltage steps were the same as
above. Subtraction of IK from ITotal represented IA. To con-
trol for changes in cell size, the current density (pA/pF)
was measured by dividing the current amplitude by whole
cell membrane capacitance, which was obtained by read-
ing the value for whole cell input capacitance cancellation
directly from the patch-clamp amplifier.
Western blotting
Trigeminal ganglion from CFA-treated rats (2 days) or
age-matched control rats were dissected out and lyzed
in 120 μl of radioimmunoprecipitation assay buffer con-
taining 1% NP-40, 0.5% Na deoxycholate, 0.1% SDS,
PMSF (10 μl/ml), and aprotinin (30 μl/ml; Sigma). The
cell lysates were then microfuged at 15,000 rpm for
30 min at 4°C. The concentration of protein in hom-
ogenate was determined using a BCA reagent (Beyotime,
CHN). Twenty micrograms (20 μg) of proteins for CBS
expression were loaded onto a 10% Tris-HCl SDS-PAGE
gel (Bio-Rad, Hercules, CA). After electrophoresis, the
proteins were electrotransferred onto polyvinyldifluoride
membrane (Millipore) at 200 mA for 2 hrs at 4°C. The
membrane was incubated in 25 ml of blocking buffer
(1XTBS with 5% w/v fat-free dry milk) for 2 hrs at room
temperature. The membrane was then incubated with
the primary antibodies for overnight at 4°C. Primary
antibodies used were mouse anti-CBS (1:1000; Abnova),
mouse anti-CSE (1:1000, Abnova) and mouse anti-actin
(1:1000; Chemicon, Temecula, CA). After incubation,
the membrane was washed with TBST (1XTBS and 5%
Tween 20) three times for 15 min each and incubated
with anti-mouse peroxidase-conjugated secondary anti-
body (1:4000; Chemicon) for 2 hrs at room temperature.
The membrane was then washed with TBST three times
for 15 min each. The immunoreactive proteins were detected
by enhanced chemiluminescence (ECL kit; Amersham
Biosciences, Arlington Heights, IL). The bands recognized
by primary antibodies were visualized by exposure of the
membrane onto an x-ray film. All samples were normal-
ized to β-actin as control. For quantification of CBS or
CSE protein levels, the photographs were digitalized and
analyzed using a scanner (Bio-Rad imaging system Bio-
Rad GelDoc XRS+).
Real-time PCR for CBS mRNA
Purification of total RNA from TG tissues was per-
formed with RNeasy Mini Kits (Qiagen, Valencia, CA,
USA) according to the manufacturer’s instructions. RNA
purity and concentration were determined spectrophoto-
metrically. RNA was only used if the ratio between spec-
trophotometer readings (260 nm: 280 nm) was between
1.8 and 2.0. A reverse transcription and first strand
cDNA synthesis was performed using an Omniscript RTkit (QIAGEN) (Invitrogen) following the supplier’s in-
structions. For detecting mRNA level of cbs, real time
PCR was conducted on an ABI 7500 Fluorescent Quan-
titative PCR system (Applied Biosystems, Bedford, MA,
USA). A 25 μL reaction mixture contained 1 μL of
cDNA from samples, 12.5 μL of 2 × SYBR Green qPCR
Master Mix, 1 μL primers (10 mM), and 10.5 μL of
RNase/DNase free water. Amplification conditions in-
volved a pre-incubation at 95°C for 1 min followed by
amplification of the target DNA for 40 cycles (95°C for
10 s and 60°C for 20 s), and the fluorescence collection
at 60°C. Melting curve analysis was performed at a linear
temperature transition rate of 0.5°C/s from 60°C to 95°C
with continuous fluorescence acquisition. Relative ex-
pression level for cbs gene was normalized by the Ct
value of β-actin (internal control) using a 2-ΔΔCt relative
quantification method. The sequences of the primers for
cbs were 5’-GAACCAGACGGAGCAAACAG-3′ (forward)
and 5′-GGCGAAGGAATCGTCATCA-3′ (reverse), giv-
ing a 121-bp amplicon. All experiments were repeated
three times for reproducibility.
Measurement of hydrogen sulfide (H2S) concentration
H2S level was measured using a previously described
method [26,27]. Briefly, trigeminal ganglion tissues were
homogenized in 250 μl of ice-cold 100 mM potassium-
phosphate buffer (pH = 7.4) containing trichloroacetic
acid (10% w/v). Zinc acetate (1% w/v, 250 μl) was
injected to trap the generated H2S. A solution of N,N-di-
methyl-p-phenylenediamine sulfate (20 μM; 133 μl) in
7.2 M HCl and FeCl3 (30 μM; 133 μl) in 1.2 M HCl was
added. Absorbance at 670 nm of the resulting mixture
(250 μl) was determined after 10 min using a 96-well
microplate reader (Bio-Rad). The H2S concentration of
each sample was calculated against a calibration curve of




(AOAA) and L-cysteine (L-Cys) were purchased from
Sigma–Aldrich (St. Louis, MO) and was freshly prepared
in normal external solution. AOAA or L-Cys or an equal
volume of normal saline (NS) used as control was injected
subcutaneously into the TMJ area. For behavioral studies,
AOAA at different doses (3, 6 and 9 mg/kg body weight)
was injected once 2 days after CFA injection. L-Cys at dif-
ferent doses (50, 500 and 1000 μM in 100 μl) was injected
into TMJ area in healthy control rats. Escape threshold
was determined after injection of AOAA or L-Cys. For
patch clamp experiments, AOAA at 9 mg/kg body weight
was injected 8 hrs after CFA injection three times a day
for consecutive 2 days. Dissection of TGs was performed
30 minutes after last injection of AOAA or NS.
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Rotarod testing was examined using a previously de-
scribed method [28]. Briefly, rats were first placed on the
rotarod at a given speed (from 5 rpm to 15 rpm) 1 day
or 2 consecutive days for training before the beginning
of the experiment. After this training most rats step vol-
untarily from the operator’s hand onto the rod. The
length of time that each rat is able to stay on the rod at
a given rotation speed (15 rpm) was recorded before and
after administration of AOAA.Data analysis
All values are given as mean±SEM. No neuron with a rest-
ing membrane potential more depolarized than -40 mV
was included in the data analysis. Statistical analyses were
conducted using commercial software OriginPro 8 (Origi-
nLab, US) and Matlab (Mathworks, US). Normality was
checked for all data before analyses. Statistical signifi-
cance was determined by two sample t-Test, Mann-
Whitney test, Dunn’s post hoc test following Friedman
ANOVA, Kruskal-Wallis ANOVA followed by Tukey post
hoc test, as appropriate. P < 0.05 was considered statisti-
cally significant.Figure 1 CBS inhibitor attenuates mechanical hyperalgesia in CFA rat
threshold in response to von Frey filaments. (A) Injection of CFA into TMJ
of the same volume of normal saline (NS, n = 9) did not alter ET (open bars
lasted for ~6 days (n = 9, *p < 0.05, compared with that before CFA injectio
Subcutaneous injection of AOAA 8 hours after CFA injection had a significa
manner. ET was increased 30 minutes after administration of AOAA in CFA
compared with NS, Kruskal-Wallis ANOVA followed by Tukey post hoc test)
volume of NS had no significant effects on ET in healthy control rats (n = 1
(L-Cys), an endogenous substrate for CBS to generate H2S, produced mech
dependent manner (n = 6 rats for each group, *p < 0.05 compared with NSResults
CBS inhibitor AOAA attenuates inflammatory
hyperalgesia
Escape threshold (ET) was determined by measuring
mechanical threshold in response to von Frey filaments.
The ET was significantly lower after CFA injection than
those before CFA injection (PRE). The lowered ET started
8 hours after CFA injection and lasted for ~6 days, indi-
cating an establishment of mechanical hyperalgesia in rats.
The ET was returned to normal level 9 days after CFA in-
jection (Figure 1A, n = 9, *p < 0.05 compared with before
CFA injection, Dunn’s post hoc test following Friedman
ANOVA). In contrast, injection of the same volume of
normal saline (NS) into TMJ area did not significantly
alter the ET in rats (Figure 1A, n = 9, Dunn’s post hoc test
following Friedman ANOVA).
To determine whether the endogenous H2S producing
enzyme CBS are involved in CFA-induced mechanical
hypersensitivity, AOAA, a potent CBS inhibitor, was ad-
ministrated subcutaneously in TMJ. Injection of AOAA
had a significant effect on ET in CFA rats (Figure 1B). ET
was increased 30 minutes after administration of AOAA in
CFA rats, in a dose dependent manner (Figure 1B, n = 13
rats for each group; *p < 0.05 compared with NS, Kruskal-s. Escape threshold (ET) was determined by measuring mechanical
area of rats (n = 9) significantly decreased ET (filled bars) while injection
) significantly. The lowered ET started 8 hours after CFA injection and
n (PRE), Dunn’s post hoc test following Friedman ANOVA). (B)
nt effect on the ET in CFA rats, in a dose- and time-dependent
rats in a dose dependent manner (n = 13 rats for each group, *p < 0.05
. (C) Subcutaneous injection of AOAA at 9 mg/kg body weight or same
3 rats for each group). (D) Subcutaneous injection of L-Cysteine
anical hyperalgesia in healthy control rats, in a dose- and time-
, Kruskal-Wallis ANOVA followed by Tukey post hoc test).
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doses of AOAA (3, 6, 9 mg/kg body weight) were used in
this study. The optimized dose for AOAA to produce the
maximal effect was 9 mg/kg body weight. We then deter-
mined the time course of AOAA effects. The effect of
AOAA at 3, 6 and 9 mg/kg lasted ~30, 60 and 90 min, re-
spectively (Figure 1B, n = 13 rats for each group; *p < 0.05
compared with NS, Kruskal-Wallis ANOVA followed by
Tukey post hoc test). These results suggest that inhibition
of H2S production attenuated mechanical hyperalgesia in
rats with TMJ inflammation. To further confirm the effect
of AOAA in CFA rats, AOAA was administrated in age-
matched healthy control rats. AOAA at 9 mg/kg or NS
had no significant effects on the ET in healthy control rats
(Figure 1C, n = 13 rats for each group), suggesting that this
agent did not act as a non-specific analgesic and that CBS
do not normally participate in the responses to mechanic
stimulation in normal conditions.
If H2S generated endogenously contribute to the de-
velopment of mechanical hyperalgesia in CFA-injected
animals, the exogenous H2S would expect to produce
hyperalgesia in healthy rats. This is supported by our
previous report that administration of H2S donor NaHS
produced mechanical hyperalgesia [15]. To further as-
certain H2S effect, we administered L-Cys, an endogen-
ous substrate for CBS to generate H2S, in healthy rats in
present study. Similar to NaHS [15], L-Cys produced
mechanical hyperalgesia in a dose-dependent manner
(Figure 1D, n = 6 rats for each group, *p < 0.05 compared
with NS, Kruskal-Wallis ANOVA followed by Tukey
post hoc test). The hyperalgesic effect of L-Cys persisted
for ~45 min. These data demonstrate that H2S produces
an acute hyperalgesic effect in healthy rats, which par-
tially mimics the effect induced by CFA injection.
CFA injection increases expression of CBS in TG
To determine whether CFA injection upregulated CBS
expression, TGs were dissected out 2 days after CFA orFigure 2 CFA injection enhances expression of CBS in TG. (A) CBS pro
compared with age- and sex-matched controls (NS, n = 4; CFA, n = 4, *p < 0
was not significantly altered in CFA-injected rats when compared with con
mRNA expression in TGs in CFA-injected rats (NS, n = 4; CFA, n = 4, *p < 0.0NS injection. The reason why selected this time point to
perform experiments is because the escape threshold at
this point is at bottom of the time curve (Figure 1A) and
also to minimize the suffering from pain. As shown in
Figure 2A, CFA injection dramatically increased CBS ex-
pression in TGs (*p < 0.05 compared with NS, n = 4 for
each group, two sample t-Test). We also examined expres-
sion of cystathionine-γ-lyase (CSE), another endogenous
H2S producing enzyme. Expression of CSE was not altered
significantly 2 days after CFA injection when compared
with controls (Figure 2B). To determine whether CFA in-
jection altered CBS expression at gene level, the expres-
sion of CBS mRNA was examined 2 days after CFA
injection. CFA injection markedly enhanced CBS mRNA
level when compared with NS group (Figure 2C, *p < 0.05,
n = 4 for each group, two sample t-Test).
CFA injection enhances excitability of TMJ neurons
To determine whether CFA injection altered neuronal ex-
citability, we next investigated intrinsic membrane proper-
ties including resting membrane potentials (RP), current
threshold (rheobase), and pattern of firings in response to
depolarizing current stimulation of TG neurons innervat-
ing the TMJ. TMJ innervating TG neuron, labeled by DiI
(Figure 3A), were identified under microscope (Figure 3B).
The average diameter was 25.9 ± 0.75 μm (n = 22 cells) for
control rats and 24.6 ± 5.39 μm (n = 26 cells) for CFA rats
(Table 1). The resting membrane potentials of DiI labeled
TG neurons were significantly altered after CFA injection
(Figure 3C, **p < 0.01, compared with NS, Normality
test following Mann-Whitney test). The average RP
were -54.23±1.07 mV (n = 22) and -50.69±0.81 mV (n = 26)
for control and CFA rats, respectively. Rheobase, the min-
imal stimulation current to evoke one action potential (AP),
was also determined. The average rheobase of TMJ neurons
was 0.18±0.02 nA (n = 22) and 0.11±0.01 nA (n = 26) for
control and CFA rats, respectively. CFA injection led to a
marked reduction in rheobase when compared with thattein expression was greatly enhanced in CFA-injected rats when
.05, compared with NS, two sample t-Test). (B) CSE protein expression
trols. (C) RT-PCR assays demonstrated a significant upregulation of CBS
5, compared with NS, two sample t-Test).
Figure 3 CFA injection increases excitability of TMJ neurons. (A) An example of a Dil-labeled TG neuron (arrow). A star showing the place
where a neuron is not labeled by DiI. (B) A phase image of the same TG neuron labeled by DiI is shown on the bottom (arrow) and the neuron
not labeled by DiI is shown on the top (*). Bar = 50 μm. Patch clamp recordings were performed on DiI labeled TG neurons. A total of 22
DiI-labeled neurons from control rats and 26 DiI-labeled neurons from CFA-treated rats were recorded under current clamp conditions. (C) CFA
injection significantly depolarized resting membrane potentials (RP) of TG neurons innervating TMJ (**p < 0.01, compared with NS, Mann-Whitney
test). (D) CFA injection markedly reduced rheobase (*p < 0.05, compared with NS, Mann-Whitney test). (E) Example of action potential (AP) trances
evoked by 2X (left) and 3X (right) rheobase current stimulation of TMJ innervating TG neurons from NS- (top) and CFA- (bottom) injected rats.
(F) Bar graphs showed that CFA injection greatly increased numbers of AP evoked by 2X (left) and 3X (right) rheobase current stimulation
(*p < 0.05, **p < 0.01, compared with NS, Mann-Whitney test).
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Mann-Whitney test). In addition, the numbers of APs in
response to a current stimulation (2×, 3× rheobase,
300 ms in duration) were examined 2 days after CFA in-
jection. The number of AP numbers in response to 2×Table 1 Membrane characteristics of TMJ innervating TG
neurons of control (NS) and CFA-injected rats
NS (n = 22) CFA (n = 26) p Value
Cell size (μm) 25.9 ± 0.75 24.6 ± 5.39 NS
Cm (pF) 29.16 ± 1.23 26.53 ± 1.09 NS
RP (mV) -54.23 ± 1.07 -50.69 ± 0.81 < 0.01
Rin (MΩ) 635.5 ± 44.2 643.6 ± 21.8 NS
Rheobase (nA) 0.18 ± 0.02 0.11 ± 0.01 < 0.05
# of APs (2Xrheobase) 5.32 ± 0.79 8.27 ± 0.78 < 0.05
# of APs (3Xrheobase) 7.5 ± 1.10 12.58 ± 1.20 < 0.01
AP Threshold (mV) -29.33 ± 1.77 -30.68 ± 1.42 NS
AP Amplitude (mV) 97.51 ± 2.34 87.35 ± 3.22 <0.05
AP Overshoot (mV) 41.24 ± 2.28 35.43 ± 2.84 NS
AP Duration (ms) 2.49 ± 0.17 2.05 ± 0.12 NS
# of APs (Ramp 100 pA) 1.32 ± 0.43 2.31 ± 0.76 NS
# of APs (Ramp 300 pA) 8.19 ± 1.65 15.15 ± 1.76 < 0.01
# of APs (Ramp 500 pA) 17.45 ± 2.87 29.15 ± 2.40 < 0.01
Values are mean ± SEM, with sample size in parenthesis; Cm, membrane
capacitance; RP, Resting membrane potential; AP, Action potential; Rin, Input
resistance; NS, No significance; p values were determined by two sample
t-Test or Mann-Whitney test where appropriate.and 3× current stimulation in age-matched control rats
was 5.32±0.79 (n = 22) and 7.5±1.10 (n = 22), respect-
ively. In CFA injected rats, the number of AP numbers
in response to 2× and 3× current stimulation was 8.27±0.78
(n = 26) and 12.58±1.20 (n = 26), respectively (Figure 3E
and F, *p < 0.05, **p < 0.01, Mann-Whitney test). Figure 3E
are representative voltage trace in response to 2× and 3×
rheobase current stimulations 2 days after application of
NS (top) or CFA (bottom). This increase in spike numbers
was not due to a change in cell input resistance because
cell input resistance was not altered significantly after
CFA injection (NS vs. CFA; 635.5 ± 44.2 MΩ vs. 643.6 ±
21.8 MΩ, p > 0.05, two sample t-Test, Table 1). These
results suggest that CFA injection increases neuronal
excitability.
To further compare numbers of AP firing of TG neu-
rons after CFA injection, we also used 1-second ramp
current stimulation from 0 to 300 pA or 500 pA (Figure 4).
Because APs elicited by ramp current stimulation showed
adaptation in some neurons, we counted only overshoot-
ing APs (i.e., AP with peak >0 mV). Figure 4A shows the
representative voltage traces in response to 300 pA (left)
and 500 pA (right) ramp current stimulation 2 days after
injection of NS (top) or CFA (bottom). The average num-
bers of APs in control rats were 8.19±1.65 (n = 22) and
17.45±2.87 (n = 22) for 300 pA and 500 pA, respectively.
In CFA injected rats, the average numbers of APs were
15.15±1.76 (n = 26) and 29.15±2.40 (n = 26) for 300 pA
and 500 pA, respectively. Injection of CFA significantly
Figure 4 CFA injection increases the number of action potentials evoked by ramp current stimulation. (A) Examples of APs evoked by
300 pA (left) and 500 pA (right) ramp current stimulation from NS (top) and CFA-injected (bottom) rats. (B) Bar graph showed a significant
increase in numbers of APs evoked by 300 pA (left) and 500 pA (right) ramp current stimulation in NS- or CFA-injected rats (**p < 0.01, compared
with NS, Mann-Whitney test). (C) Bar graph representing the mean time to first spike (TTFS) in response to a 300 pA (left) or 500 pA (right) ramp
current injection from NS or CFA-injected rats (*p < 0.05, compared with NS, Mann-Whitney test). (D) Mean interspike interval (ISI) in a spike train
of TMJ neurons responding to a 300 pA ramp current stimulation from NS- or CFA-injected rats (*p < 0.05 compared with NS, Mann-Whitney test).
(E) Mean ISI in a spike train of TMJ neurons responding to a 500 pA ramp current stimulation from NS- or CFA-injected rats (*p < 0.05 compared
with NS, Mann-Whitney test).
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ramp current injection (Figure 4B). Again, this increase
in spike number was not due to a change in cell input
resistance because cell input resistance was not altered
significantly after CFA injection (NS vs. CFA; 635.5 ±
44.2 MΩ vs. 643.6 ± 21.8 MΩ, p > 0.05, two sample t-Test,
Table 1). Furthermore, the time to first spike (TTFS) was
significantly decreased by CFA injection (NS vs. CFA:
465.97±35.70 ms vs. 364.22±33.18 ms, *p < 0.05 at the 300
pA depolarization, Figure 4C left; 382.01±45.30 ms vs.
228.56±20.08 ms, *p < 0.05 at the 500 pA depolarization,
Figure 4C right). A change in the interspike interval (ISI)
in response to a 300 pA and 500 pA current injection was
seen both at the beginning of a train of spikes (after 1th
spike, NS vs. CFA: 126.48±13.87 ms vs. 69.99±4.66 ms,
*p < 0.05 at the 300 pA depolarization, Figure 4D;
92.18±8.06 ms vs. 56.15±2.61 ms, *p < 0.05 at the 500
pA depolarization, Figure 4E) and in the latter parts of
the train (after 6th spike, NS vs. CFA: 52.60±3.38 ms vs.
43.11±2.88 ms, *p < 0.05 at the 300 pA depolarization,
Mann-Whitney test, Figure 4D; 43.37±4.06 ms vs.
33.49±1.93 ms, *p < 0.05 at the 500 pA depolarization,
Mann-Whitney test, Figure 4E), suggesting an effect of
CFA injection on spike frequency adaptation of TMJ
neurons.Several additional membrane properties were also ex-
amined. AP threshold, AP duration and overshoot, and
membrane input resistance were not significantly altered
in TMJ projecting neurons from rats after CFA or NS in-
jection (Table 1).
CFA injection suppresses voltage-gated potassium current
of TG neurons
Because changes in spike frequency and activation thresh-
olds suggest that there was an alteration in voltage-gated
potassium (KV) channels, we next performed patch-clamp
recordings to examine these currents under voltage-clamp
conditions. Na+ in the control external solution was re-
placed with equimolar choline and the Ca2+ concentration
was reduced to 0.03 mM, as described previously [29-31].
A depolarization step from -50 to +90 mV in 10-mV in-
crements with duration of 400 ms activated all KV chan-
nels (ITotal; Figure 5A). The peak current-voltage (I-V)
curves are shown in Figure 5D. However, CFA injection
greatly decreased peak current density in DiI-labeled
neurons (*p < 0.05, compared with NS, two sample t-Test,
Figure 5G). The mean peak current density of total
voltage-gated potassium current from NS-treated rats was
644.89 ± 64.58 pA/pF (n = 7), and the mean peak current
density of total voltage-gated potassium current from
Figure 5 CFA injection suppresses voltage-gated potassium currents. Currents were measured at different holding potentials. For total
voltage-gated potassium current (ITotal), the membrane potential was held at -100 mV and voltage steps were from -50 to +90 mV with10-mV
increments and 400 ms duration. For sustained voltage-gated potassium current (IK), the membrane potential was held at -50 mV and the voltage
steps were the same as above. Currents generated by these two protocols were subtracted to produce IA. (A) Examples of total KV currents
recorded from NS (top) and CFA-treated rats (bottom). (B) Examples of IK recorded from NS (top) and CFA-treated rats (bottom). (C) Examples of
IA recorded from NS (top) and CFA-treated rats (bottom). The peak ITotal (D), IK (E) and IA (F) versus voltages (I-V) were plotted from cells acutely
dissociated from rats treated with NS or CFA. Bar graphs showed the mean peak ITotal (G), IK (H), and IK (I) densities from NS and CFA-treated rats.
The current density (pA/pF) was calculated by dividing the current amplitude by cell membrane capacitance. CFA injection caused a significant
reduction of ITotal (G, *p < 0.05, compared with NS, two sample t-Test). The IK density was significantly reduced (H, *p < 0.05, compared with NS,
two sample t-Test) while the IA was not altered significantly after CFA injection (I).
Miao et al. Molecular Pain 2014, 10:9 Page 9 of 15
http://www.molecularpain.com/content/10/1/9CFA-treated rats was 462.13 ± 37.82 pA/pF (n = 7). Because
there were two main types of KV currents (IA and IK) de-
scribed in nociceptive TG neurons, we then isolated these
two kinetically different KV currents by manipulating the
holding membrane potential. A depolarization step -50 to
+90 mV in 10-mV increments with duration of 400 ms ac-
tivated most of the sustained KV channels (Figure 5B) but
not A-type KV channels. Subtraction of IK from ITotal rep-
resented IA (Figure 5C). In this experiment, IK density was
remarkably reduced after CFA application (*p < 0.05, com-
pared with NS, two sample t-Test, Figure 5H). The mean
peak current density of IK from NS-treated rats was
326.19 ± 37.84 pA/pF (n = 7), and the mean peak current
density of IK from CFA-treated rats was 173.55 ± 23.08
pA/pF (n = 7). Whereas IA density was not significantly
changed ( p > 0.05, compared with NS, two sample t-Test,
Figure 5I). The mean peak current density of IA from NS-
treated rats was 336.62 ± 70.31 pA/pF (n = 7), and themean peak current density of IA from CFA-treated rats
was 288.58 ± 47.09 pA/pF (n = 7).
CBS inhibitor AOAA reduces the H2S level and reverses
hyperexcitability of TMJ neurons
Since AOAA reversed the reduction in escape threshold
in CFA rats, we next investigated whether AOAA treat-
ment reduced the production of H2S in TG. As expected,
administration of AOAA (i.p., 9 mg/kg three times daily
for consecutive 2 days) drastically reduced the level of
H2S in TGs when compared with CFA rats (Figure 6A,
*p < 0.05, n = 9 rats for each group). We next deter-
mined whether administration of AOAA reversed hy-
perexcitability of DiI-labeled TMJ neurons from CFA
injected rats. The resting membrane potentials (RPs)
were -49.55 ± 0.59 mV (n = 20) and -51.60 ± 0.59 mV
(n = 20) for NS and AOAA, respectively. AOAA treatment
significantly hyperpolarized RPs of TG neurons from CFA
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Besides, AOAA treatment dramatically enhanced rheobase
when compared with the NS-treated group (Figure 6C,
*p < 0.05, Mann-Whitney test). The rheobase were 0.10 ±
0.01 nA (n = 20) and 0.15 ± 0.02 nA (n = 20) for NS and
AOAA, respectively. AOAA treatment resulted in a signifi-
cant reduction in the number of APs elicited in response to
2× and 3× rheobase current injections (Figures 6D and E,
*p < 0.05, **p < 0.01, Mann-Whitney test, two sample
t-Test). Figure 6C are representative voltage traces in re-
sponse to 2× (left) and 3× (right) rheobase current injec-
tions after application of NS (top) or AOAA (bottom).
The numbers of AP evoked by 2× rheobase current stimu-
lation were 7.40±0.82 (n = 20) and 4.60±0.62 (n = 20) for
NS- and AOAA-treated group, respectively. The numbers
of AP evoked by 3× rheobase current stimulation were
11.40±1.27 (n = 20) and 7.85±0.98 (n = 20) for NS- and
AOAA-treated group, respectively. This decrease in spike
number was not due to a change in cell input resistance
(NS vs. AOAA; 670.90±29.55 MΩ vs. 581.10±46.43 MΩ,
p > 0.05, two sample t-Test).
To further compare numbers of AP firing of TMJ neu-
rons after AOAA treatment, we also used 1-second ramp
current stimulation from 0 to 300 pA or 500 pA (Figure 7).
Figure 7A shows the representative voltage traces in re-
sponse to 300 pA (left) and 500 pA (right) ramp current
stimulations 2 days after injection of NS (top) or AOAAFigure 6 CBS inhibitor AOAA reduces the H2S level and reverses neur
three times daily for consecutive 2 days) drastically reduced the level of H2
(B) Administration of AOAA markedly hyperpolarized RP (CFA + AOAA, n =
(C) AOAA treatment significantly increased rheobase (CFA + AOAA, n = 20;
AOAA treatment also greatly reduced numbers of AP evoked by 2X (left) a
NS, n = 20, *p < 0.05, **p < 0.01, Mann-Whitney test, two sample t-Test).(bottom). The average numbers of APs in NS-treated rats
were 15.3±1.90 (n = 20) and 29.6±2.82 (n = 20) for 300 pA
and 500 pA, respectively. In AOAA treated rats, the
average numbers of APs were 8.1±1.73 (n = 20) and
15.65±2.65 (n = 20) for 300 pA and 500 pA, respectively.
Injection of AOAA significantly decreased the number
of APs evoked by 300 or 500 pA ramp current injection
(Figures 7A and B, **p < 0.01, Mann-Whitney test, two
sample t-Test). Again, this decrease in spike number
was not due to a change in cell input resistance (NS vs.
AOAA; 670.90±29.55 MΩ vs. 581.10±46.43 MΩ, p > 0.05,
two sample t-Test). Furthermore, the time to first spike
(TTFS) was significantly increased by AOAA treatment
(NS vs. AOAA: 344.47±32.22 ms vs. 441.03±37.19 ms,
*p < 0.05 at the 300 pA depolarization, Figure 7C left;
230.61±22.09 ms vs. 320.69±55.81 ms, *p < 0.05 at the
500 pA depolarization, Figure 7C right). A change in
interspike interval (ISI) in response to a 300 pA and 500
pA current injection was seen both at the beginning of a
train of spikes (after 1th spike, NS vs. AOAA: 65.52±3.18 ms
vs. 115.09±11.19 ms, *p < 0.05 at the 300 pA depolarization,
Figure 7D; 53.97±2.85 ms vs. 78.96±8.01 ms, *p < 0.05 at
the 500 pA depolarization, Figure 7E) and in the latter parts
of the train (after 6th spike, NS vs. AOAA: 41.01±2.42 ms
vs. 53.44±5.12 ms; *p < 0.05 at the 300 pA depolarization,
Mann-Whitney test, Figure 7D; 32.80±2.76 ms vs.
40.17±1.88 ms, *p < 0.05 at the 500 pA depolarization,onal hyperexcitability. (A) Administration of AOAA (i.p., 9 mg/kg
S in TGs when compared with CFA rats (n = 9 rats for each group).
20, CFA + NS, n = 20, *p < 0.05, compared with NS, two sample t-Test).
NS, n = 20, * p < 0.05, compared with NS, Mann-Whitney test). (D, E)
nd 3X (right) rheobase current stimulation (CFA + AOAA, n = 20, CFA +
Figure 7 CBS inhibitor AOAA reduces the number of action potentials evoked by ramp current stimulation. (A) Examples of APs by 300
pA (left) and 500 pA (right) current stimulation from NS (top) and AOAA (bottom) treated rats. (B) Bar graph showed a significant decrease in
numbers of APs evoked by 300 pA and 500 pA ramp stimulation in AOAA-treated rats (CFA + AOAA, n = 20, CFA + NS, n = 20, **p <0.01,
compared with NS, Mann-Whitney test, two sample t-Test). (C) Bar graph representing the mean time to first spike (TTFS) in response to a 300 pA
(left) or 500 pA (right) ramp current injection from NS or AOAA-treated rats (*p < 0.05, compared with NS, Mann-Whitney test). (D) Mean interspike
interval (ISI) in a spike train of TMJ neurons responding to a 300 pA ramp current stimulation from NS- or AOAA-treated rats (*p < 0.05 compared with
NS, Mann-Whitney test). (E) Mean ISI in a spike train of TMJ neurons responding to a 500 pA ramp current stimulation from NS- or AOAA-treated rats
(*p < 0.05 compared with NS, Mann-Whitney test).
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AOAA treatment on spike frequency adaptation of
TMJ neurons.
CBS inhibitor AOAA reverses voltage-gated potassium
current of TG neurons
Since AOAA reversed hyperexcitability of TMJ neurons
in CFA rats, we next investigated whether AOAA sup-
pressed current density of KV current in DiI labeled TG
neurons. Rats were divided into two groups: AOAA group
treated with AOAA (9 mg/kg) and NS group treated with
the same volume of normal saline. The mean peak current
density of total voltage-gated potassium current from
AOAA-treated rats was 508.91 ± 61.75 pA/pF (n = 8), and
the mean peak current density of total voltage-gated po-
tassium current from NS-treated rats was 369.81 ± 31.84
pA/pF (n = 10). AOAA treatment significantly reversed
the reduction of peak amplitude of ITotal (Figures 8A, D
&G, *p < 0.05, compared with NS, two sample t-Test). As
expected, AOAA treatment remarkably increased the
mean peak current density of IK (*p < 0.05, compared with
NS, two sample t-Test, Figures 8B, E&H). The mean peak
current density of IK from AOAA-treated rats was 283.74 ±
42.38 pA/pF (n = 8), and the mean peak current density ofIK from NS-treated rats was 163.66 ± 11.79 pA/pF (n = 10).
However, IA density was not significantly changed (p > 0.05,
compared with NS, two sample t-Test, Figures 8C, F&I).
The mean peak current density of IA from AOAA-treated
rats was 251.17 ± 38.39 pA/pF (n = 8), and the mean peak
current density of IA from NS-treated rats was 202.99 ±
24.48 pA/pF (n = 10).
Discussion
The present study was designed to determine the effects
of CBS-H2S signaling on nociceptive processing in trigem-
inal ganglion cells innervating the TMJ of rats under
pathophysiological conditions. We first examined the role
of CBS-H2S signaling on excitability of TG neurons. Injec-
tion of a CBS inhibitor reduced excitability of TG neurons
in rats with TMJ inflammation induced by CFA injection.
The AOAA treatment appears to modulate the response
of a TG neuron to suprathreshold inputs and therefore
have an important role in determining the output of the
neuron. Specifically, injection of AOAA led to a significant
decrease in spiking activity in response to current injec-
tion. AOAA treatment reduced the number of action po-
tentials evoked at any given current injection, enhanced
threshold of excitation, increased latency to first spike and
Figure 8 CBS inhibitor AOAA increases voltage-gated potassium current. Currents were measured at different holding potentials. For total
voltage-gated potassium current (ITotal), the membrane potential was held at -100 mV and voltage steps were from -50 to +90 mV with10-mV
increments and 400 ms duration. For sustained KV current (IK), the membrane potential was held at -50 mV and the voltage steps were the same
as above. Currents generated by these two protocols were subtracted to produce IA. (A) Examples of total KV currents recorded from NS (top)
and AOAA-treated CFA rats (bottom). (B) Examples of IK recorded from NS (top) and AOAA-treated CFA rats (bottom). (C) Examples of IA recorded
from NS (top) and AOAA-treated CFA rats (bottom). The peak ITotal (D), IK (E) and IA (F) versus voltages (I-V) were plotted from cells acutely dissociated
from CFA rats treated with NS or AOAA. Bar graphs showed the mean peak ITotal (G), IK (H), and IK (I) densities from NS and AOAA-treated CFA
rats. The current density (pA/pF) was calculated by dividing the current amplitude by cell membrane capacitance. AOAA treatment caused a
significant increase in ITotal (G, *p < 0.05, compared with NS, two sample t-Test). The IK density was significantly increased (H, *p < 0.05,
compared with NS, two sample t-Test) while the IA was not altered significantly after AOAA treatment in CFA rats (I).
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Importantly, the reduced escape threshold produced by
CFA injection was antagonized by the presence of
AOAA, confirming that these effects are likely mediated
through CBS signaling. Collectively, these data suggest
that CBS-H2S signaling plays a crucial role in inflamma-
tory pain in TG cells and most likely acts to modulate
TG neuronal excitability.
A unique feature of this study is the local in vivo use
of AOAA. AOAA, as a potent inhibitor for CBS, has
been widely used in many fields [32]. However, AOAA
could produce non-specific effects such as a blunted re-
sponse to hypoxia when it is used systematically or in a
large dose [33]. Therefore, we chose subcutaneous injec-
tion of AOAA to avoid possible side effects produced by
AOAA. To exclude possible role of AOAA on rat motor
coordination/function, the Rota-Rod test was performed
in the present study. No significant difference (p > 0.05)
was observed in the time that animals remained on therota-rod at 15 rpm before and after AOAA treatment
(data not shown), indicating that AOAA-induced anal-
gesic effect is not due to the reduced motor function. Sub-
cutaneous injection of AOAA significantly attenuated the
pain behavior in CFA rats, in a dose- and time-dependent
manner. No significant effect was seen in control animals,
suggesting that this was not a non-specific analgesic ef-
fect. This also suggests that the role of CBS pathway in
signaling TMJ information may not be as important in
health as in the sensitized pathophysiological state. Since
cystathionine-γ-lyase (CSE), another endogenous H2S pro-
ducing enzyme, was not altered in terms of expression
after CFA injection, we focused our study on the effect of
CBS. If H2S generated endogenously contribute to the de-
velopment of mechanical hyperalgesia in CFA-injected an-
imals, application of exogenous H2S to healthy rats should
mimic the effects of CFA. Therefore, we applied L-Cys, an
endogenous substrate for CBS to generate H2S, to healthy
rats and assessed behavioral responses. Addition of L-Cys
Miao et al. Molecular Pain 2014, 10:9 Page 13 of 15
http://www.molecularpain.com/content/10/1/9mimics the CBS production of H2S. Together with our
previous report [15], these data suggest that CBS-H2S sig-
naling plays a crucial role in inflammatory pain in TMJ.
Another important change is the inflammation-
induced upregulation of CBS expression observed in
TGs. CFA injection upregulated CBS expression at both
protein and mRNA levels. This is similar to those ob-
served in rat hindpaw [13], colon [34] and gastric [14]
afferents. That such a change has been observed in affer-
ents innervating three different tissue types inflamed
with different stimuli suggests that an increase in CBS
expression may be a general response to inflammatory
injury. However, expression of CBS was not altered in
the rat model of sciatic nerve injury model [13] and
bone cancer pain model (personal unpublished data),
suggesting a disease-specific upregulation of CBS expres-
sion. The basis for such an increase is unclear but may
be associated with epigenetic mechanisms such as DNA
demethylation [13] or regulated by transcriptional fac-
tors such as nuclear factor kappa B [14] under patho-
physiological conditions. The detailed molecular
mechanisms underlying the upregulation of CBS gene
expression in TMJ afferents need to be further
investigated.
Much of the published data to date suggest that H2S,
formed by two enzymes CBS and CSE, regulates key
neuronal functions. These include induction of long-
term potentiation and modulation of NMDA receptor
currents in the hippocampus under physiological condi-
tions [35,36]. Recently, H2S has also been reported to
enhance excitability of stomach [34], colon [11], and
hindpaw [13] innervating dorsal root ganglion neurons
in vitro. In present study, we provide direct evidence for
CBS signaling involved in hypersensitivity of TMJ in-
nervating TG neurons in the setting of TMJ inflamma-
tion. We first confirmed that TMJ inflammation
enhanced neuronal excitability. This conclusion is based
on several findings shown in Figures 3 and 4. Firstly,
TMJ neurons from animals with inflammation displayed
marked depolarization of resting membrane potential.
Secondly, these neurons exhibited lower current thresh-
olds for initiating an AP compared with controls.
Thirdly, these neurons had enhanced firing frequencies
in response to a standardized stimulation compared with
controls. Finally, TMJ neurons from CFA-treated rats
had enhanced firing frequencies and reduced latency to
first spike and interspike interval (ISI) in response to a
ramp current stimulation when compared with controls.
This is similar to that reported by Flake et al. [16]. Of
note is that such reduced ISI might be influenced by the
net inward current (i.e. the reduced IK) during the ISI
and thus influence firing frequency. Interestingly, both
the pattern of inflammation-induced excitability changes
and the associated changes in passive properties,properties of the action potential waveform, or specific
ion channels varies from study to study. For example,
the inflammation-induced increase in cell body size was
observed in TMJ [16], bladder [37] and gastric [38] affer-
ents as well. That such a change has been observed in
afferents innervating three different tissue types inflamed
with different stimuli suggests that an increase in cell
body capacitance seems to be a general response to in-
flammatory tissue injury. However, no significant change
in cell body size was observed in pancreas afferents in a
rat model of chronic pancreatitis [39]. It is possible that
differences between these studies as well as the present
study reflect differences in experimental methods (i.e.,
type of inflammation, timing between induction of in-
flammation and study of neurons, species and sex of ani-
mals). Nevertheless, our data suggest that CFA-induced
TMJ inflammation enhanced neuronal excitability, which
is presumably mediated by CBS-H2S signaling. We then
provided direct evidence to support our hypothesis.
Local administration of CBS inhibitor AOAA reversed
the enhanced excitability of TMJ neurons as evidenced
by an increase in rheobase, a reduction in the numbers
of evoked action potentials, and hyperpolarization of
resting membrane potentials. These changes in electro-
physiological properties of TMJ neuron support the
changes in pain behaviors after AOAA treatment. To-
gether with our previous report that H2S enhanced ex-
citability of TG neurons [15], the present study further
indicates that H2S modulates membrane properties of
rat TG neurons under pathophysiological conditions.
The ionic basis for the reduced excitability by AOAA
remains unknown but may reflect an alteration in the
biophysical properties and/or expression of one or more
ion channel(s) such as voltage-gated sodium, potassium
and calcium channels [7,40]. H2S has been reported to
modulate activities of different channels such as KATP
currents [12], T-type calcium [8] and sodium channel
current [13] of DRG neurons, and the sustained potas-
sium current of TG neurons [15]. Since we have previ-
ously demonstrated that CBS was co-localized with
KV1.1 and KV1.4 and that H2S donor NaHS suppressed
the IK current density [15], we continued to examine the
effect of AOAA on KV currents in present study. AOAA
treatment significantly enhanced the IK current density,
supporting the hypothesis that IK plays an important role
in TMJ inflammatory pain. Of note is that contributions
from other ion channels cannot be excluded in the
present study. Further researches into detailed mecha-
nisms of TMJ pain are definitely necessary.
In conclusion, the roles of CBS-H2S signaling in ner-
vous system function are still being deciphered but it is
becoming rapidly clear that CBS-H2S signaling can have
profound influences on brain and cellular activity. The
data presented here demonstrate yet another locus for
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CBS-H2S signaling. As we continue to uncover the wide-
ranging effects of CBS-H2S activation, we will hopefully
reveal potentially new strategies for therapeutic interven-
tions in a wide array of common diseases such as chronic
pain.
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